Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’’s disease and other dementias

By Abraham Jean-Daniel   Calvayrac-Pawlowski Sophie   Cobo Sandra   Salvetat Nicolas   Vicat Guillaume   Molina Laurence   Touchon Jacques   Michel Bernard-Franççois   Molina Franck   Verdier Jean-Michel   Fareh Jeannette   Mourton-Gilles Chantal  

Biomarkers, Vol. 16, Iss. 2, 2011-03 ,pp. : 161-171

Informa Healthcare

Access to resources Recommend Favorite

A biomarker for severity of Alzheimer’s disease: ¹H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam

By Kork Felix   Gentsch André   Holthues Jan   Hellweg Rainer   Jankowski Vera   Tepel Martin   Zidek Walter   Jankowski Joachim  

Biomarkers, Vol. 17, Iss. 1, 2012-02 ,pp. : 36-42

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma

By Bekris Lynn M.  

Biomarkers, Vol. 18, Iss. 5, 2013-08 ,pp. : 455-466

Informa Healthcare

Access to resources Recommend Favorite

Oxidative imbalance in alzheimer’s disease

By Zhu Xiongwei   Lee Hyoung-gon   Casadesus Gemma   Avila Jesus   Drew Kelly   Perry George   Smith Mark  

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 205-217

Humana Press, Inc

Access to resources Recommend Favorite

Molecular basis of Alzheimer’s disease

By Grigorenko A.   Rogaev E.  

Molecular Biology, Vol. 41, Iss. 2, 2007-04 ,pp. : 294-307

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite